Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 2

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
INTRODUCTION: Neuroinflammation is co-occurring phenomenon during pathological processes in the nervous system. Key player in this process is microglia. As sensing cells, microglia recognize any morbid changes and if needed, become activated. As moderate activation of microglia is beneficial, excessive one however, leads to more severe degeneration of tissue and inhibition of its endogenous regeneration. One way to prevent this situation is to modulate or inhibit microglia activation. AIM(S): Aim of this study was to use gene silencing technique to influence microglial activation. By targeting key proteins – NF‑κB, MyD‑88 and TRIF, we intended to decrease inflammatory signaling network. METHOD(S): To optimize gene silencing, we used stable murine microglia BV-2 cell line. To induce their activation, cells were exposed to lipopolysaccharide (LPS). After stimulation, cells were transfected with designed siRNA sequences targeting NF‑κB, MyD‑88 and TRIF. Efficacy of transfection was assessed by evaluating expression of NF‑κB, MyD‑88, TRIF as well as IL‑1β, IL‑6, TNF‑α at mRNA (qPCR) and protein level (Western blot). Optimized sequences of siRNA were then used on primary microglia isolated from adult mice in same scheme. RESULTS: Our results showed that siRNA can successfully inhibit activation of microglia in vitro after stimulation with LPS. Significant decrease was observed in expression of signaling proteins. However, depending on targeted factor, different decrease patterns were observed for IL‑1β, IL‑6 and TNF‑α. Thus, mixture of siRNA was combined to achieve most successful effect. Importantly, no or slight effect on microglia activation was observed due to siRNA transfection alone. CONCLUSIONS: Our results provide a new method to successfully limit microglia activation with siRNA technique. It may open new ways to modulate neuroinflammation and protect nervous system from severe degeneration. However, for effective use of such approach in vivo, optimization of delivery and stability of silencing molecules is needed.
INTRODUCTION: Neurodegenerative disorders are acquired or inherited diseases of the nervous system, in which the main causative mechanism is loss of specific subtypes of neurons. Due to the fact that neurodegeneration processes are poorly understood, present therapies allow only for a delay in the progression or decrease in symptoms. An interesting approach is modelling of cellular interactions within the human brain using pluripotent stem cells. Induced pluripotent stem (iPS) cells are unique among other cells through their differentiation potential and self-renewal ability, thus they can play a key role in modeling the disease. Recent achievements in differentiation of stem cells enable generation of dopaminergic neurons from human iPS cells. AIM(S): The aim of this work was to obtain iPS cells from healthy volunteers and Parkinson’s disease (PD) patients with the idiopathic form of the disease and to compare dopaminergic neurons derived from iPS cells of both groups. METHOD(S): To achieve this goal, peripheral blood mononuclear cells were reprogrammed with Sendai virus infection. Generated iPS lines were able to differentiate into the 3 germ layers in vivo (teratoma formation assay) and were also positive for alkaline phosphatase. Embryonal markers were evaluated by RT‑PCR. The differentiation of human iPS cells into dopaminergic neurons was performed. Expression of neuronal markers on differentiated cells was analyzed by immunostaining and RT‑qPCR. RESULTS: Differences between neurons generated from PD patients with the idiopathic form of the disease and healthy volunteers were observed. CONCLUSIONS: Moreover, preliminary results show immense potential for further analysis of dopaminergic neurons from patients with idiopathic forms of PD. FINANCIAL SUPPORT: The project was supported by a grant from the National Science Centre in Poland 2015/17/B/NZ5/00294.
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.